Bitolterol mesylate

甲磺酸比托特罗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBitolterol mesylate
Drug Alias NameBitolterolum双甲苯苄醇比妥特罗双甲苯喘定甲磺酸盐Produrol +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors agonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/12/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeR03AC17
Related LinksWikipediaDrugBankKEGG